- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Low-affinity immunoglobulin epsilon Fc receptor (FCER2), more commonly known as CD23, is a type II transmembrane glycoprotein involved in regulation of IgE-mediated immune responses, B-cell activation, and adaptive immunity. CD23 Antibody / B-Cell Activation and IgE Receptor Marker is useful for studying germinal center biology, follicular immune architecture, lymphoid differentiation, and immune signaling pathways associated with activated B-cell populations. CD23 is primarily expressed on mature B lymphocytes, follicular dendritic cells, activated macrophages, and select epithelial and hematopoietic cell populations.
CD23 antibody, also referred to as FCER2 antibody or Low-affinity IgE receptor antibody in the literature, recognizes the low-affinity receptor for immunoglobulin E. CD23 functions in regulation of IgE synthesis, antigen presentation, B-cell proliferation, and cytokine-mediated immune signaling. The protein localizes predominantly to the cell membrane but can also undergo proteolytic cleavage to generate soluble CD23 fragments involved in immunomodulatory signaling pathways. Through these activities, CD23 contributes to coordination of allergic responses, humoral immunity, and lymphocyte activation.
Within lymphoid tissues, CD23 expression is strongly associated with germinal center-associated B cells and follicular dendritic cell meshworks. In immunohistochemistry applications, CD23 staining is frequently used to evaluate follicular architecture, identify follicular dendritic cell networks, and characterize B-cell lineage populations in reactive and neoplastic lymphoid tissues. CD23 is widely used in hematopathology research involving chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, and related B-cell proliferative disorders. The marker is particularly valuable when interpreted together with additional B-cell lineage and germinal center-associated markers.
CD23 also plays an important role in allergic inflammation and immune regulation through interactions with IgE and cytokine-responsive signaling pathways. Elevated CD23 expression has been associated with allergic disease, asthma, chronic inflammatory states, and altered immune activation. Beyond hematologic biology, CD23 has been investigated in epithelial immunity, antigen processing pathways, and regulation of adaptive immune responses within mucosal tissues.
CD23 Antibody / B-Cell Activation and IgE Receptor Marker clone FCER2/3592 is supported by western blot, immunohistochemistry, and HuProt microarray specificity validation data. Western blot analysis demonstrates the expected CD23 band in Daudi B-cell lineage lysates, while immunohistochemistry highlights germinal center-associated immune cell populations within tonsillar lymphoid tissue. The included HuProt microarray specificity validation data further supports selective target recognition suitable for studies involving B-cell activation, immune regulation, and lymphoid tissue characterization.
Explore additional immune and lymphoid research targets in our Immunology Antibodies page featuring markers involved in B-cell signaling, germinal center biology, adaptive immunity, and hematologic disease research.
Optimal dilution of the CD23 Antibody / B-Cell Activation and IgE Receptor Marker should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A recombinant human FCER2/CD23 protein fragment within amino acids 48-321 was used as the immunogen for the CD23 antibody protein microarray validated clone FCER2/3592.
Store the CD23 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
FCER2 antibody, Low affinity IgE receptor antibody, Fc epsilon receptor II antibody, B-cell activation marker antibody, Germinal center B-cell marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.